Tag | Content |
---|
EnhancerAtlas ID | HS145-17683 |
Organism | Homo sapiens |
Tissue/cell | NHBE |
Coordinate | chr3:107845990-107847410 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr3:107846640-107846661 | ATGGTGAAACCGAAAGAAAGA | - | 6.06 |
|
| Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
SE_10290 | chr3:107841403-107854329 | CD19_Primary | SE_11097 | chr3:107839285-107856894 | CD20 | SE_18342 | chr3:107841754-107855286 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19381 | chr3:107842585-107853685 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_39519 | chr3:107845775-107847908 | Jurkat | SE_49846 | chr3:107845856-107854954 | RPMI-8402 | SE_59782 | chr3:107839193-107854206 | Ly4 | SE_62894 | chr3:107840796-107857058 | Tonsil | SE_66319 | chr3:107845775-107847908 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr3 | 107846269 | 107846510 | chr3 | 107846155 | 107846323 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I108123 | chr3 | 107841863 | 107848040 |
|
Enhancer Sequence | TAGTGTTCAA TAGCCTACTG GACATTAGGG TAAAAGATTT TTTTAAAAAA TTTTTAAAAA 60 TTATGAGTGA GGAATGTAGT GGGCCATTTG TGTTTCAGAG TGGAGGGCTC TGCTATTAGG 120 CAGACATTTG ACTTTTCACT CGGCACATCC ACATTCCAGC CAGTCTCCCA GTGAATGGTG 180 ATAAGCTGGC CCTGATCATG CCTGTATGGC TACACCCCTC TCTGCCTTGT TGAGGCCTGA 240 GTTAATTTGA AGTGTTGCAG AGACATGTGT TGATTCCTGT GGCTACAAGG CTCCCGGAAG 300 TGTCAGAGGC AGAGGTATTG TTTCCTGGGA GGGGTGTCTT CCTGTGTACC GCTGGTGTAC 360 CACTGGTGTA TGCCTGCCCA GAAGTTTGTT CTTTCACACC CACAGGGCCA CCTGAAGAAA 420 CAGAGATAGG GTCTCCCACG GAATGGGGCA GCAAAAGAAG TAAAGCAAAA GTGAAGAAAA 480 GAGAAATAGG GGGCAGCAAG TGTTCAGGAA AAGGGGGGTC AGATAGGAGA GAGAAGCAAA 540 GAGAAAAATC AAAGTGTATA AAGCAAGTGG CGGGACTCGC TGAGCTGTAG GTGTAGTAAG 600 AAGCTATCAC ACCAGCCTGT TAGCTCCCTG CAGGATTCAC AGCATCAAGG ATGGTGAAAC 660 CGAAAGAAAG AAAAGGTAGT TCAGCAGGAA AGATCAACAA AGACAAATCC TGGGACGAAT 720 CCAAGCTGCT ATTAGAATCG AACCAAGCAA AGATATGACC ACCTATGTTA GCGACCTGTT 780 GCTTAGTTTA TTTTAAATGA AACTCATATT TACTTGATTA ATTTAGAAAA TCTGAGATTC 840 ACTAGAGCAG GAACTTTGCC TTCCTCAGTT CCTAGACCAG TACCAGTTAC ATGGTGAAGG 900 CTTAATAAAT ATTTATAAAG GAATGTTAAT TAATCAGCTG GTAATTGATA TGTAAAATTG 960 CTTGAAATTA TAAAATAATA GTGACAACTA AAAGTAATAC AGTGCATAAT AGTTTAGAAA 1020 TCAACTTCAT GATTATCTCA TTTAATCCTC ACACAGTCCC ATCAGGTATC ACCATGATCA 1080 TCCTCACCTT AAGAATAAGA CACTAGTTCG AAGCCACTCT ATGATTTGTG CCTGGGATTT 1140 TAATCAATAT TCTCTGATGC AAAAGCCAAC CTAGCACTTT GCCTCTTTGG TCATGTTGTA 1200 TGTGCCCACT CATGATAAGT GCTTGGTATA TTTAAGTAGT CATATCCATA GTAGGTATAG 1260 GTATCAGTTT GGATTCTCCA GGAAGCAGAA TTACGAGTGT ATGAGGAGGA GGGGGTCACA 1320 CCTGGGAAAG ATAAAGGGAG ACTGATCAAG GTGGGGCAAT GTATTAGTCC ATTTTCACAC 1380 TGCTGTAAAA AAATACCTGA GCCTGGGCAA TTTATAAAGG 1420
|